SCHEMBL16503574

SCHEMBL16503574

CC=C(OC)c1ccc2cccc(-c3ncc(F)cc3F)c2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 5/20 0.33
GABRB3 P28472 5/20 0.33
GABRA5 P31644 5/20 0.33
GABRA3 P34903 5/20 0.33
HTR5A P47898 6/20 0.33
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HSP90AA1 P07900 1/20 0.31
GABRA1 P14867 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16502728 0.85 NPC1 (0.43) GABRA5HTR5AKDM4ENPC1ALDH1A1
SCHEMBL7914783 0.85 GABRG2 (0.34) GABRG2GABRB3GABRA5GABRA3HTR5A
SCHEMBL16503575 0.85 GABRG2 (0.35) GABRG2GABRB3GABRA5GABRA3HTR5A
SCHEMBL16502739 0.80 PLA2G2D (0.45) GABRG2GABRB3GABRA5GABRA3HTR5A
SCHEMBL7919762 0.77 KDM4E (0.34) KDM4ENPC1ALDH1A1MAPTHPGD
SCHEMBL16502705 0.74 S1PR1 (0.42) KDM4ENPC1ALDH1A1TP53GLA
SCHEMBL16502840 0.74 HTR5A (0.58) HTR5A
SCHEMBL16502737 0.74 TP53 (0.42) HTR5AKDM4ENPC1ALDH1A1TP53
SCHEMBL7915988 0.74 HTR5A (0.39) HTR5AKDM4ENPC1ALDH1A1TP53
SCHEMBL16503545 0.74 LMNA (0.40) KDM4ENPC1ALDH1A1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2394987-A1 ACYLGUANIDINE DERIVATIVE Astellas Pharma Inc. (JP) 2011-12-14 EP disclosed